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In view of the growth of clinical risk prediction models using genetic data, there is an increasing 
need for studies that use appropriate methods to select the optimum number of features from a 
large number of genetic variants with a high degree of redundancy between features due to linkage 
disequilibrium (LD). Filter feature selection methods based on information theoretic criteria, are 
well suited to this challenge and will identify a subset of the original variables that should result in 
more accurate prediction. However, data collected from cohort studies are often high‑dimensional 
genetic data with potential confounders presenting challenges to feature selection and risk prediction 
machine learning models. Patients with psoriasis are at high risk of developing a chronic arthritis 
known as psoriatic arthritis (PsA). The prevalence of PsA in this patient group can be up to 30% and 
the identification of high risk patients represents an important clinical research which would allow 
early intervention and a reduction of disability. This also provides us with an ideal scenario for the 
development of clinical risk prediction models and an opportunity to explore the application of 
information theoretic criteria methods. In this study, we developed the feature selection and psoriatic 
arthritis (PsA) risk prediction models that were applied to a cross‑sectional genetic dataset of 1462 
PsA cases and 1132 cutaneous‑only psoriasis (PsC) cases using 2‑digit HLA alleles imputed using the 
SNP2HLA algorithm. We also developed stratification method to mitigate the impact of potential 
confounder features and illustrate that confounding features impact the feature selection. The 
mitigated dataset was used in training of seven supervised algorithms. 80% of data was randomly 
used for training of seven supervised machine learning methods using stratified nested cross 
validation and 20% was selected randomly as a holdout set for internal validation. The risk prediction 
models were then further validated in UK Biobank dataset containing data on 1187 participants 
OPEN
1Centre for Genetics and Genomics Versus Arthritis,Centre for Musculoskeletal Research,Faculty of 
Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, 
Manchester M13 9PT, UK. 2Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, 
King’s College London, London, UK.  3Department of Medicine, University of Cambridge, Cambridge, UK.  4NIHR 
Manchester Musculoskeletal Biomedical Research Unit,Central Manchester NHS Foundation Trust, Manchester 
Academic  Health  Science  Centre,  Manchester,  UK.  5NIHR Leeds Biomedical Research Centre, Leeds Teaching 
Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Disease, University of Leeds, Manchester, 
UK. 6Royal National Hospital for Rheumatic Diseases and Dept Pharmacy and Pharmacology, University of Bath, 
Bath, UK.  7Division  of  Epidemiology  and  Public  Health, University  of  Nottingham, Nottingham, UK.  8St  John’s 
Institute of Dermatology, Guys and St Thomas’ Foundation Trust, London, UK. 9St John’s Institute of Dermatology, 
Faculty of Life Sciences and Medicine, King’s College London, London, UK. 10Dermatology Centre, Salford Royal 
NHS Foundation Trust, University of Manchester, Manchester, UK. *A comprehensive list of consortium members 
appears at the end of the paper. *email: farideh.jalali@manchester.ac.uk
2
Vol:.(1234567890)
Scientific Reports |        (2021) 11:23335  | https://doi.org/10.1038/s41598-021-00854-x
www.nature.com/scientificreports/
and a set of features overlapping with the training dataset.Performance of these methods has been 
evaluated using the area under the curve (AUC), accuracy, precision, recall, F1 score and decision curve 
analysis(net benefit). The best model is selected based on three criteria: the ‘lowest number of feature 
subset’ with the ‘maximal average AUC over the nested cross validation’ and good generalisability to 
the UK Biobank dataset. In the original dataset, with over 100 different bootstraps and seven feature 
selection (FS) methods, HLA_C_*06 was selected as the most informative genetic variant. When 
the dataset is mitigated the single most important genetic features based on rank was identified as 
HLA_B_*27 by the seven different feature selection methods, consistent with previous analyses of 
this data using regression based methods. However, the predictive accuracy of these single features in 
post mitigation was found to be moderate (AUC= 0.54 (internal cross validation), AUC=0.53 (internal 
hold out set), AUC=0.55(external data set)). Sequentially adding additional HLA features based on 
rank improved the performance of the Random Forest classification model where 20 2‑digit features 
selected by Interaction Capping (ICAP) demonstrated (AUC= 0.61 (internal cross validation), AUC=0.57 
(internal hold out set), AUC=0.58 (external dataset)). The stratification method for mitigation of 
confounding features and filter information theoretic feature selection can be applied to a high 
dimensional dataset with the potential confounders.
Precision medicine has the potential to have an enormous impact on healthcare; however, for this potential to 
be fully realised, we need to be able to accurately predict the outcome of patients in different clinical scenarios. 
The wealth of genetic and clinical data that is now available for medical research provides an unprecedented 
opportunity to explore machine learning (ML) approaches for the prediction of the clinical  outcomes1,2.
The use of genetic data in the development of risk prediction models presents a number of challenges mainly 
attributable to the large number of genetic variants available following imputation strategies and the high degree 
of redundancy between features due to linkage disequilibrium (LD). Many of these genetic variants may be 
completely irrelevant to the specific question being asked, or redundant in the context of other features. This 
may contribute to the increased computational burden of processing many similar features and the potential 
of overfitting to irrelevant aspects of the data. Therefore, it is important to identify a subset of the original vari-
ables (features) that enable more accurate prediction by the elimination of irrelevant or redundant information.
Filter methods, based on the information theoretic criteria, are particularly suited to these challenges as they 
are computationally less intensive than other methods, less likely to overfit and they evaluate the relationships of 
the features independent of any specific  classifier3. In addition, information theory based on mutual information 
has the advantage of accounting for both linear and non-linear dependencies that exist between features whereas 
some traditional statistical methods such as logistic and lasso regression assume an additive genetic  model4,5. This 
is of particular importance for many autoimmune diseases where genetic variants in the human leukocyte antigen 
(HLA) genes confer a substantial proportion of disease risk and studies have demonstrated highly significant 
non-additive  effects5. In addition, the construction of a genetic prediction model may be confounded by issues 
such as population stratification, often represented by principal components, and ascertainment bias attributed 
to the method of sample collection. Here we explore the use of information theory based filter feature selection 
methods on HLA data to classify psoriatic arthritis (PsA)6,7 from cutaneous-only psoriasis. This is a clinically 
important question as approximately 30 percent of patients with psoriasis may develop PsA potentially leading to 
long-term disability and lower quality of  life8–10. The ability to predict which psoriasis patients have a higher risk 
of developing PsA could lead to intervention strategies that would limit disability. We have previously shown that 
ascertainment bias in this data caused by the preferential collection of psoriasis cases with a young age of disease 
onset leads to  confounding11 and here we illustrate the use of a stratification method to deal with such issues. 
Finally, we present an independently validated genetic prediction model based in information theoretic methods.
The following contributions are made:
• The development of a stratification approach to mitigate confounding
• We show that confounding features impacts the feature selection and can be successfully mitigated by strati-
fication
• We demonstrate the utility of filter information theoretic methods for feature selection in highly complex 
genetic datasets such as the HLA region
• We present an externally validated risk prediction model for PsA using HLA data
  To our knowledge, no comparable techniques with stratification, information theoretic feature selection 
and external validation have been applied previously to the analysis of the HLA region in PsA and psoriasis
Methods
Sample cohorts. Our training dataset consisted of 1462 PsA patients recruited from rheumatology centres 
within in the UK. Classification of PsA was performed by a rheumatologist based on coexistence of psoriasis and 
inflammatory arthritis in accordance with the CASPAR (ClASsification criteria for Psoriatic ARthritis) classifi-
cation  system12 where possible. Recruitment was performed with full written informed consent from the patients 
(UK PsA National Repository MREC 99/8/84), all methods followed relevant guidelines and legistlation. This 
study was approved by Central Manchester NHS Research Ethics Committee. Data on 1132 cutaneous-only pso-
riasis patients (PsC) were available through the Biomarkers of Systemic Treatment Outcomes in Psoriasis study 
(BSTOP)11. Patients were recruited to BSTOP via the British Association of Dermatologists Biologics Interven-
tions Registry (a UK pharmacovigilance registry, BADBIR.org.uk) from dermatology clinical within the UK. 
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PsC classification in BSTOP is based on interview questioning of rheumatologist diagnosed PsA at baseline and 
follow-up visits (twice annually for the first three years of follow-up, then annually).
Imputation of HLA alleles. Genotyping of DNA from PsA patients was performed with the Illumina 
Immunochip array as previously  described13. Genotyping of DNA from PsC patients was performed at King’s 
College London using the Illumina HumanOmniExpressEx- ome-8v1-2_A as previously  described14. Quality 
control was consistent across both dataset following conventional standards of data missingness (SNP and sam-
ple), SNP allele frequency, Hardy-Weinberg equilibrium and sample outliers based on relatedness and ancestry. 
Datasets were combined retaining an intersection of high quality SNPs. Quality control of UK Biobank genotype 
data is described in details by Bycroft et al15. Imputation of SNPs, amino acids and HLA alleles for training and 
validation datasets was carried out using SNP2HLA software package (version 1.0.3) using the T1DGC refer-
ence  panel11. Variants with an information score < 0.9 or a MAF < 0.01 were excluded and all analyses were 
conducted using imputed dosage. Following quality control, the training dataset consisted of 2093 patients with 
172 HLA alleles(2-digits,4-digits), 683 amino acids, 5862 SNPs. To ensure that our trained model is applicable to 
the validation data in UK Biobank, the data was filtered to only contain features that are shared between internal 
training cohort and external validation cohort. This analysis focuses on the 70 HLA 2-digits features and three 
potential confounders (age of psoriasis onset (aao), the top two principal components ’PC1’ and ’PC2’ for miti-
gation of population  stratification16). The four stages research pipeline is illustrated in Fig. 1: data pre-processing, 
confounding mitigation, feature selection and model development for the subtype prediction.
Stratification development. To mitigate the effect of confounders in feature selection a ‘stratification’ 
 method17 was developed to control for the three confounders of concern where the association between each fea-
ture and the outcome is tested within different strata of the confounding feature. During stratification, individu-
als are divided into several strata on the basis of confounders where the number of individuals in the strata may 
or may not be equal. Figure 2 illustrates the methodology of this approach for the stratification where ‘Feature 2’ 
has been assigned as the known age of psoriasis onset confounder. The minimum and maximum value for ‘Fea-
ture 2’ was determined and restricted to narrow width bins ‘0-20’ years ‘21-40’, ‘41-60’, ‘61-80’ and ‘81-100’. The 
Frequency distribution of each target label (‘PsC’=‘0’, ‘PsA’=‘1’) was balanced in each age boundary by random 
sampling with replacement(bootstrap)18. For instance, in Fig. 2 in ‘Stratification Unit’ the number of patients 
in age boundary ‘61-80’ for PsC is ten less than PsA patients and the frequency distribution of two classes with 
target 0 and 1 was balanced by the inclusion of 10 random samples in target class 0. The same procedure was 
applied to ‘PC1’ and ‘PC2’ where patients(n) are divided into two strata (− 1,0), [0,1).
Information theoretic feature selection. Filter methods select features based on a performance meas-
ure regardless of the employed data modeling algorithm and separate the classification and feature selection 
 components3. Filter methods are generally applied as pre-processing steps, with subset selection procedures 
that are independent of the learning algorithm and the defining component of filter based methods is scoring 
criterion, which is often as ‘relevance index’. The relevance index denotes how useful each feature is likely to be 
for the ML classification methods. Although this leads to a faster learning process, it is possible for the criterion 
used in the pre-processing step to result in a subset that may not work very well downstream in the learning 
Figure 1.  Research Pipeline.
Figure 2.  The potential confounders were mitigated by stratification.
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algorithm. Univariate and multivariate methods are two categories for all filter based methods. Univariate meth-
ods, the scoring criterion only consider the relevancy of features while ignoring the feature redundancy. Mutual 
information is univariate feature selection approach (Shannon, 1948)19,20 measures the amount of information 
shared by an input feature X and class label (target) Y. Where the lower case x or y is possible values that the 
variables X and Y can adopt from the alphabet X and Y respectively in (1). To obtain this, we need to estimate 
the distribution of px and py respectively.
Mutual Information Maximization (MIM) method given by (2) examines the mutual information between 
a class label Y and a feature Xk, where K is the top  features21. MIM assumes that all the features are independent 
and it does not account any dependencies between the features.
Multivariate method investigates the multivariate interaction within features and the scoring criterion is a 
weighted sum of feature relevancy and redundancy. The information theoretic methods investigate the multivari-
ate interaction within features and the scoring criterion is weighted sum of feature relevancy and redundancy. 
Multivariate feature selection methods are described as follows. Joint Mutual Information (JMI) was proposed 
by Yang and Moody (1999)22,23. JMI is the information between the targets and a joint random variable defined 
by pairing the candidate Xn with each current feature. The redundancy term full captures by JMI.
Minimal-Redundancy-Maximal-Relevance (mRMR) given by (4) was proposed by Peng et al24. This takes 
the mean of redundancy term and it elemenated the conditional term. In equation (4), n is size of a feature set.
Conditional Mutual Information Maximization (CMIM) given by (6) was proposed by Fleuret (2004)25 and 
is probably the most-well known recent criterion. CMIM measures the information between a feature and the 
target and it is conditioned on each current feature. The interaction information is the term in square brackets 
which can be both negative and positive. A negative value indicate that the shared information between Xk and 
Y has decreased as the result of including Xn.
Mutual information feature selection (MIFS) does not consider conditional redundancy (g = 0), but it does 
incorporate the redundancy penalty (Brown et al., 2012).
Double input symmetrical relevance (DISR) aims to better include such complimentary features by expand-
ing  JMI26. Disr normalises the information provided by a feature by how well the given feature complements 
the other features.
The interaction capping (ICAP) approximated by following equation.
We focus on seven filter feature selection (FS) methods: mutual information feature selection (MIFS), mutual 
information maximisation (MIM), joint mutual information (JMI), minimal-Redundancy-Maximal-Relevance 
(mRMR), conditional mutual information maximisation (CMIM), Interaction Capping (ICAP) and Double Input 
Symmetrical Relevance (DISR)27. We selected these methods based on computational efficiency, popularity in 
the literature and publicly available implementations, which increases their usability. The description of each 
feature selection can be found in supplementary section 1. Each feature is assigned a rank in order of their FS 
score and the top K features were selected. Predefined requirements for a certain number of features or other 
stopping criterion can inform the value of K21,28.
Figure 3 shows our methodology for feature selection. We created 100 random samples with replacement 
(Bootstraps)18 from the original data and the top subset of features were obtained for each FS methods. For 
information theoretic criteria we estimated the necessary distributions using histogram estimators and features 
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In ‘Feature Selection Aggregator’ the outputs vote ‘V’ and rank ‘R’ are generated respectively. The vote ‘V’ for a 
features criteria defines the majority voting over 100 bootstraps. The rank ‘R’ defines the average rank over 100 
bootstraps as the rank of each feature in the top selected features can vary in each bootstrap.
Once this ranking has been computed, a feature subset composed of the best feature subset was created. For 
instance, Feature 1 with vote=90 and rank ‘R=3.5’ over 100 bootstraps is selected as the top ‘1’ feature subset. 
We incrementally selected top features ranging from (n=1,10, … 70) using each of the seven feature selection 
methods. This subset of selected features was then used as an input to each of seven supervised machine learn-
ing (ML) algorithms.
The top selected feature subset may vary with respect to each FS criterion. We therefore proposed overall 
ranking Fig. 3 with the ‘Technique Vote’, the ‘Average Bootstraps Vote’ (ABV) and ‘Average Bootstrap Rank’(ABR) 
that explore the rank of features across ‘seven different FS techniques’. The ‘Technique Vote’ is a selection of 
feature by FS criteria. The ‘Average bootstraps vote’ and ‘Average bootstrap rank’ are defined by equations 9 
and 10 respectively.
All these feature selection methods are compared with the case when all of the 70 HLA 2-digits features are fed 
into the classifier for prediction. All feature selection methods are publicly available from the package skfea-
ture(1.00) feature open access repository of Python(3.6.10) programming language which provides individual 
rankings to each feature in the database.
Supervised risk prediction model development and internal validation. In this study, risk predic-
tion models for PsA were developed using seven supervised ML algorithms:29–31 Logistic Regression (LR), Ada-
Boost, XGBOOST, Random Forest (RF), K-nearest neighbor classifier (KNNC), Decision Tree (DT) and Gauss-
ian naive bayes (NB)29. For each feature subset the response measurement is PsA (class=1) and PsC (class=0). 
The original set of examples provides the training data and the learning algorithm has been trained and validated 
using stratified nested cross-validation. Many of the machine learning algorithms employed have one or more 
hyper-parameters that must be selected to optimise model performance. The most optimal hyperparameter for 
each ML model have been obtained using 5-2 fold nested cross validation stage.The purpose of our nested cross-
validation was to find an unbiased view of the overall expected performance of each model, so the hyperparam-
eter tuning process in this step only help to find the most accurate version of each algorithm in each nested-cross 
validation fold. The aim in this stage is only to evaluate and compare the learning power of each algorithm using 
different folds of data and removing any bias in the process. Thus, to achieve the optimal hyperparameters for 
each ML model we re-trained and performed a hyperparameter tuning for all the algorithms using the entire 
training data set. These hyperparameters are then used to evaluate the performance of each model on the test 
dataset.
External validation of risk prediction models. Ultimately, fully independent external validation with 
data available at the time of PsA prediction development is important. Here we use data from UK Biobank for 
external validation to test the generalisability of seven developed ML classifiers on PsA data. The assessment 
is for reproducibility rather than transportability as the external data is very similar to the PsA-MD data  set32. 
Figure 4 presents our pipeline for internal model development and external validation. 80% of data was ran-
domly used for training of ML classifiers using 5-2-fold stratified nested cross validation and 20% was selected 
randomly as a holdout set for internal validation.
(9)ABV =
The sum of votes number (v) in each FS criteria
Number of FS techniques
(10)ABR =
The sum rank of feature (R) in each FS criteria
Number of FS techniques
Figure 3.  Methodology for feature selection.
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There are 448 different models with post mitigation trained using a combination of ‘number of features 
(1,10,...70)’, ‘7 feature selection methods’, ‘7 ML Model type’. We used the whole data and the optimal hyper-
parameter to test the best generated models in the UK Biobank dataset. Therefore, for each ML models 448(all 
models)/7(MLmodels)= 64 different combinations have been generated and the models with the maximal average 
AUC in nested cross validation is selected as the best model and tested for the external validation.
All machine learning analyses were performed in Python (using the numpy, pandas, sklearn, matplotlib, and 
XGBOOST packages), which provides a user-friendly interface to access many machine-learning algorithms in 
Python. We used AUC, precision recall curve, precision (positive predictive value (PPV)), recall (true positive 
rate or sensitivity) and F1 score to evaluate the performance of the ML classifiers.
Results
We developed a stratification method to control for known confounding for population stratification (two prin-
cipal components) and age of psoriasis onset. We then used a range of information theory feature selection 
methods and ML supervised classification methods to develop a risk prediction model for classifying PsA from 
cutaneous-only psoriasis. The best model was then externally validated in an independent dataset from UK 
Biobank to assess the generalisability of the predictive performance.
Impact of confounding on feature selection. We investigated the impact of confounding on feature 
selection pre and post-mitigation by stratification using seven FS information theoretic criteria methods MIFS, 
MIM, JMI, mRMR, CMIM, ICAP and DISR. The FS information theoretic methods were applied to a dataset of 
1462 PsA cases and 1132 cutaneous-only psoriasis  cases13 using 2-digit 70 HLA alleles. Figure 5a,b illustrate the 
top 10 selected features for the seven FS criteria and its vote over 100  bootstraps18 pre and post-mitigation for 
the three potential confounders.
HLA_C_*06 is the genetic variant that makes the largest contribution to psoriasis susceptibility and is 
known to be highly correlated with age of psoriasis  onset11. Over 100 different bootstraps and seven FS meth-
ods HLA_C_*06 is selected as the most informative genetic variant in the original dataset Fig. 5a. After the 
mitigation of the three potential confounders, HLA_B_*27 had vote 94 for ‘DISR’ followed by HLA_B_*07 with 
the vote ‘81’ in ‘ICAP’ and HLA_DRB _01 with the vote ‘83’ in Fig. 5b. PC1 and PC2 were not observed in any 
of the top 10 features subset and the majority vote over 100 bootstraps for ‘age onset’ had dramatically dropped 
after the stratification mitigation Fig. 5b. The results demonstrate how confounding impacts the selected features 
and that the stratification mitigates this impact and this is clearly illustrated by the absence of HLA_C_*06 fol-
lowing the mitigation.
Impact of confounding on classification and internal validation. For ML classification we have 
used dynamic and fixed number of features where the main aim was to identify a subset of features which maxi-
mize the risk prediction model performance in the internal dataset and generalisability to UK Biobank as the 
external validation set. In order to compare the performance of different models on a varying number of features 
with feature step (1, 10,...70), the top feature subset were consecutively incorporated into each model pre mitiga-
tion with no confounders and post mitigation of three confounding features.
Figure 4.  Risk prediction model development and external validation.
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Figure 6 shows the AUC for hold out set for ICAP feature selection for all the seven models ‘pre mitigation 
with no confounders’ and ‘post mitigation with three mitigated confounders’. It can be observed for ICAP fea-
ture selection all classifiers show similar predictive performances. There is ≈10% drop in the performance of 
classification post mitigation of confounding features. In pre-mitigation, the highest performance around 0.63 
was obtained for LR, RF AdaBoost and NB Gaussian when the top 20 subset of features selected by ICAP were 
incorporated into these models. In the post mitigation, the AUC was 53% for the top 1 HLA feature, which 
was improved by ≈20% for 20 features in KNNC and there is drop in the AUC for other classifiers in the post 
Figure 5.  Heatmap (a) feature ranking in original dataset, Heatmap (b) of feature ranking post-mitigation 
depicting the majority vote over 100 bootstrap. The top 10 selected features (in rows) and seven features 
selection techniques in (columns).
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mitigation. In conclusion, adding more features to the models did not improve the AUC dramatically in pre and 
post mitigation (except KNNC that showed different behaviour). The Figures 2, 3, 4, 5 in supplementary were 
generated for all other feature selection methods in pre and post mitigation with obtained AUC in nested cross 
validation and hold out set. All the feature selection and classifiers show similar behaviours as ’ICAP’. The results 
of overall ranking of feature selection can be found in Figures 2, 3, 4 and 5 in supplementary
External validation of classification models. The risk prediction models were then further validated 
in the UK Biobank data set containing data on 1187 participants and a set of features overlapping with the train-
ing dataset. The validation data set had similar characteristics, although a lower proportion of admissions from 
the patients with PsA and PsC. Table 1 presents the comparison results of AUC, precision and recall of the best 
generated models out of 448 different models. The best models number are 402(LR), 303 (Adaboost), DT (416), 
XGBoost(398), KNNC (232), NB Gussain(39)and RF(184).The performance is dependent on the type of feature 
selection methods, the number of selected features and the selected prediction models. The results for accuracy 
and F1 score of the best models can be found in Table 1 supplementary.
All models for predicting risk of PsA demonstrated moderate predictive performance. In post mitigation, a RF 
model with 20 features selected by ICAP performed as the final best overall model. RF has good generalisibility 
and robustness with respect to internal-cross validation (AUC= 0.61, Precision=0.59, Recall=0.54), internal-
hold out-set(AUC= 0.58, Precision=0.54, Recall=0.45) and external validation (AUC= 0.58, Precision=0.58, 
Recall=0.59). Amongst all models KNNC (model number=232, disr, 60 features) is overfitted in UK biobank 
with AUC internal (cross validation= 0.73, hold out= 0.76) and (AUC external=0.53). Of note, Gussain (model 
number=39, mim, 10 features), DT (model number=416, disr, 10 features) have very similar AUC to RF but lower 
precision and recall. Each feature selection and classification model combination have different behaviours to the 
mitigation techniques. Variability in the classification models and feature selection methods were the main factors 
in the performance variation. Overall, classification AUC at the model development stage were comparable to 
AUC where those models were used to predict labels in UK biobank as shown in Fig. 7. Nested cross validation 
(a) Heatmap of AUC for ICAP pre-mitigation selection (b) Heatmap of AUC for ICAP post-mitigation mitigation
Figure 6.  The ICAP feature selection pre-mitigation and post-mitigation for seven classification methods. 
Heatmap depicting the predictive performance (AUC for hold out set) for different number of HLA features(in 
rows) and different classification method in (columns).
Table 1.  The best generated models out of 448 generated models.
The best models AUC % Precision% Recall%




validation Hold out External
Cross 
validation Hold out External
Cross 
validation Hold out External
402 LG disr 40 0.62 0.58 0.57 0.60 0.53 0.55 0.57 0.54 0.57
303 Adaboost jmi 60 0.66 0.64 0.54 0.62 0.59 0.52 0.61 0.64 0.60
416 DT disr 10 0.54 0.53 0.51 0.67 0.63 0.53 0.16 0.16 0.20
398 XGBoost disr 40 0.63 0.60 0.55 0.60 0.56 0.53 0.57 0.53 0.56
232 KNNC disr 60 0.73 0.76 0.53 0.73 0.74 0.53 0.74 0.76 0.52
39 NB Gussain mim 10 0.61 0.58 0.59 0.63 0.54 0.57 0.35 0.34 0.42
184 RF icap 20 0.61 0.58 0.58 0.59 0.54 0.58 0.54 0.45 0.59
9
Vol.:(0123456789)
Scientific Reports |        (2021) 11:23335  | https://doi.org/10.1038/s41598-021-00854-x
www.nature.com/scientificreports/
was sufficient to control overfitting and produced results which generalised well to the independent test sample. 
The hyperparameters for each classifier is shown in Table 2.
The Figures 8 and 9 in supplementary generated for accuracy, precision, recall and F1-score score of 448 gen-
erated models and each model respectively. Figure 8 shows Receiver operating characteristic (ROC) curve and 
precision-recall (PR) curve for predicting PsA. ROC curve of internal validation (cross validation, holdout-set), 
external validation (a) and PR curve of internal validation (cross validation, hold out-set) and external valida-
tion (b)illustrate that the best classifier RF. The results of ROC curve and PR are generated for other classifiers 
in supplementary Fig. 6 and Fig. 7 respectively. Figure 9a,b show the positive net benefit for each model within 
a specific threshold in cross validation and external validation. Probability threshold pt in the studied popula-
tion is between 25% and 75%. KNNC has the positive net benefit between [25%–75%] in cross validation but its 
performance drops, measured by AUC, as its shown in Table 1. We can observe that for our best model ‘Random 
Forest’ a positive net benefit between 45% and 60% threshold probability. The decision curve is generated for 
each model in cross validation and external datast in Fig. 10 supplementary.  
Table 2.  Machine Learning Algorithms and their Corresponding Hyperparameters.
Model Scikit-Learn package Parameter name in Scikit_Learn Package Test Range
 DT  tree.DecisionTreeCalssifier
max_features [1, 10, 20, 30, 40, 50, 60, 70]
max_depth [1, 2]
min_sample_split [2, 5, 10]
min_sample_leaf [2, 3, 4, 5]
 XGBoost  xgboost.XGBClassifier
n_estimators [100, 200, 300, 400]







 RF  ensemble.RandomForestClassifier





 AdaBoost  ensemble.AdaBoostClassifier
n_estimator [100, 200, 300, 400]
learning_rate [0.1, 0.5, 1.0]
LR linear_model.LogisticRegression C [0.01,0.1,1,10]
KNN neighbors.KNeighborsClassifire K [1, 3, 5]
NB Gaussian naive_bayes.GaussianNB — —
Figure 7.  Comparison between AUC for cross validation, hold out and external set for 448 different generated 
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Discussion
Our results clearly demonstrate the impact of confounding on both feature selection and model generalisability 
and how stratification can mitigate this effect. This is well illustrated by considering the results for HLA_C_*06, 
which is a known risk factor for early onset psoriasis (type I): we have previously shown the preferential collection 
of type I psoriasis in genetic studies can lead to ascertainment bias when compared with PsA. Our stratification 
approach mitigated this effect leading to the expected identification of HLA_B_*B27 as the predominant risk 
factor for PsA in psoriasis.
The issue of selection bias and confounding is increasingly being recognised as an important issue in the 
statistical methodology  literature33,34. The main aim of this work was to demonstrate the application of informa-
tion theory methods to genetics, in particular for feature selection in complex regions of the genome, namely the 
MHC, and in the presence of confounding. The results from our external validation confirm the generalisability 
and reliability of the AUC values obtained in the training data following mitigation by stratification. In addition, 
high dimensional data with many redundant features, such as found with genetic datasets, are a significant chal-
lenge for Machine  Learning35. Our results demonstrate the utility of information theory feature selection methods 
in complex genetic datasets, such as the HLA region, which, coupled with the fact that they are less prone to 
overfitting and computationally efficient, makes them attractive options for feature selection in genetic datasets.
Our study has several strengths: firstly, we aimed to avoid overfitting in two stages, initially at the internal 
stage where we used stratified nested cross validation and tested each model on unseen data (hold out set) 
and subsequently we externally validated the best models on a completely independent dataset. Secondly, our 
feature selection method is independent of classification methods and it does not assume an additive or linear 
(a) ROC (b) Precision
Figure 8.  (a) Receiver operating characteristic and (b) Precsion-Recall curve of the best models with internal( 
hold out and cross validation) and external model performance for RF.
(a) Decision Curve-Cross_validation (b) Decision Curve-External_Validation
Figure 9.  Decision curve analysis for seven machine learning models for prediction of psoriatic arthritis (PsA).
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relationship between the features and the outcome. Many prediction models and risk scores have been developed 
with feature selection methods based on traditional statistical approaches such as logistic and lasso regression. 
The traditional methods will fit better if the data is linearly  separable36,37. If such a linear relationship does not 
exist then the model may oversimplify complex relationships among features with non-linear interactions, lead-
ing to the potential loss of significant relevant  information38,39 which is likely to be the cases in the HLA region 
for many autoimmune diseases where non-additive effects have been  reported5,40.
The moderate performance of our prediction model in internal and external validation could be explained 
by the fact that the imputed HLA alleles are not sufficient to differentiate PsA from cutaneous-only psoriasis 
despite this being the major PsA genetic risk  factor41.
In addition, the sample size and cross-sectional nature of the dataset may also be a limitation for a training 
machine learning algorithm where the performance of risk prediction model based on ML classifiers will be 
better if the number of training samples is  large42. The research looked at the genetic variants found in the MHC 
region, so, the genetic variants outside of the MHC region may improve the prediction models performance. 
Combination of clinical data and genetics data can be used in a longitudinal fashion to improve performance.
We used classic information theoretic methods, so using two state of art models in information theory may 
improve the performance of the models and the selection of informative features.
Finally, whilst doing our utmost to ensure that the cutaneous-only psoriasis reference groups were free from 
PsA there is the potential for phenotype misclassification where a proportion of these participants have gone on 
or will go on to develop PsA. The BSTOP patients are screened for PsA with the use of a questionnaire which 
is not as efficient as screening by a rheumatologist. In this study, we can assume a certain level of undiagnosed 
PsA in the PsC group which will impact the classification  accuracy43,44. In general larger number with clearly 
characterise is important, both for PsC and PsA . In PsC, area of involvement, as well as overall Psoriasis Area 
and Severity Index (PASI) and nail disease should be taking into consideration.This would impact both model 
training and external validation.
An ML algorithm is considered non generalisable and unstable if a small change in the training set causes 
a large change in the performance of the  algorithm45. The more stable an algorithm, the more reliable are its 
results and the greater the confidence in the results. It is not adequate for an ML algorithm to perform well on 
a hold out test dataset, ideally it must also be stable and generalisable to external dataset. To our knowledge 
this is the first study to explore the application of information theoretic feature selection methods to genetic 
data. A recent study exploring machine learning methods for the prediction of PsA reported an AUC of 0.58 in 
cross-validation and 0.54 on the training dataset using five HLA variants. We have used the established ‘classic 
information theoretic methods’ which have currently available libraries. Two state of art information theoretic 
methods ‘Feature selection considering Uncertainty Change Ratio of the Class Label’ and ‘Feature redundancy 
term variation for mutual information-based feature selection’ may improve the performance of the prediction 
 models46. In conclusion, our study demonstrates the ability of stratification approach to mitigate the impact of 
confounding and we present an externally validated model based on data from the HLA genes for predicting 
risk of PsA in patients with psoriasis.
Conclusion and future work
This study showed the ability of stratification, filter feature selection methods and machine learning to identify 
risk factors and predict outcome across genetic data, which should lead to greater insights on disease risk factors 
with no prior assumption of causality. To our knowledge this is the first study to assess the impact of confounders 
on feature selection using information theoretic methods and characterise the risk of developing PsA using of 
machine learning algorithms in a UK psoriasis population. Further validation of the developed methods with 
different clinical outcomes, different biomarkers, wider spectrum of genetic variables and also different PsA 
cohorts could provide better insights about their applicability. Future research in the area should move towards 
combining clinical data and genetics in a longitudinal manner for better prediction of the outcome. MIFS, MIM, 
JMI, mRMR, CMIM, ICAP, and DISR are seven classic approaches for feature selection employed in the proposed 
methodologies. The proposed stratification and machine learning methods should be compared to two state of 
art methods models: ‘Feature selection considering Uncertainty Change Ratio of the Class Label’47 and ‘Feature 
redundancy term variation for mutual information-based feature selection’48 as the future work.
Code availability
Source codes of the programmes and algorithms used for this study are available from the corresponding author 
upon reasonable request.
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